Sarcopenia and Sarcopenic Obesity in COPD Patients with Different Levels of Severity

Katayoun Samadi, Shahram Kharabian, Atefeh Abedini, Babak Sharif Kashani, Adel Azimi, Forough Mohammadi Mohammadi

Abstract

Background: Sarcopenia is defined as loss of muscle mass with attendant loss of muscle strength and physical function and is associated with advancing age. Inflammatory condition of chronic disease leads to more rapid progression of this syndrome, which may adversely affect quality of life. The aim of this study was to determine the relationship between chronic obstructive pulmonary disease (COPD) and sarcopenia.

Methods: This study included 108 COPD patients who were treated in the pulmonary clinic at Masih Daneshvari Hospital. Patients were categorized into three groups based on Global Initiative for Obstructive Lung Disease criteria. Sarcopenic parameters including muscle mass, muscle strength, and physical performance were measured by Bioimpedance Analysis, hand grip dynamometer, and the Short Physical Performance Battery test, respectively. According to the European Working Group on Sarcopenia in Older People cutoff points and the definition of sarcopenic obesity, sarcopenic patients were diagnosed and categorized based on different COPD severity scores.

Results: The relationship between sarcopenia and COPD grading, which was assessed using multiple regression models with adjustment of confounding factors, including age, chronic diseases, and smoking, was statistically insignificant. However, by using forced expiratory volume in 1 second (FEV1) or ratio of FEV1 to forced vital capacity in this model, the results were significant (P = 0.026). A positive linear correlation was observed between skeletal muscle index (SMI) and spirometric data, which was assessed by Spearman’s correlation test. By exploring the association between sarcopenia and obesity with the one-way analysis of variance test, sarcopenic patients represented to have the minimal spirometric measures. However, this difference was only significant for actual measurements.

Conclusion: This study showed that sarcopenic COPD patients had smaller spirometric measurements and that sarcopenia and magnitude of SMI were positively correlated with obstruction severity.

Keywords

sarcopenia;COPD;spirometry

Full Text:

PDF

References

Refrence:

Rosenberg I. Summary comments: epidemiological and meth- odological

problems in determining nutritional status of older persons. Am J Clin Nutr.

;50:1231-3.

Liu CJ, Latham NK. Progressive resistance strength training for improving

physical function in older adults. Cochrane Database Syst Rev.

;3:CD002759.

Chastin SF, Ferriolli E, Stephens NA,etal. Relationship between

sedentary behaviour, physical activity, muscle quality and body composition

in healthy older adults. Age Ageing. 2012;41:111-4.

Fielding RA, Vellas B, Evans WJ,etal. Sarcopenia: an undiagnosed condition in older adults—Current consensusdefinition: prevalence, etiology, and consequences. international workinggroup on Sarcopenia. J Am Med Dir Assoc. 2011;12:249-256

Engelen MP, Schols AM, Baken WC,etal. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD.

Eur Respir J 1994;7:1793–7.

Schols AM, Soeters PB, Dingemans AM, etal. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible forpulmonary rehabilitation. Am Rev Respir Dis 1993;147: 1151–6.

Schols AM, Slangen J, Volovics L, etal. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;

:1791–7.

Rosenberg IH, Roubenoff R. Stalking sarcopenia. Ann Intern Med 1995;123:727e728.

Muscaritoli M, Anker SD, Argilés J, etal. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 2010;29:154e9.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM,etal .European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412e23.

Fleg JL, Lakatta EG. Role of muscle loss in the age-associated reduction in VO2max. J Appl Physiol 1988;65:1147e1151

Frontera WR, Hughes VA, Fielding RA, etal. Aging of skeletal muscle: A 12-yrlongitudinal study. J Appl Physiol 2000;88:1321e1326.

Hyeon-Kyoung Koo, Joo-Hyun Park, Hye Kyeong Park, etal. Conflicting Role of Sarcopenia and Obesity in Male Patients with Chronic Obstructive Pulmonary Disease:Korean National Health and Nutrition Examination Survey.ploS one 2014: 29:9(10)

Vermeeren MA, Creutzberg EC, Schols AM,etal. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006;100:1349e55.

Vermeeren MA, Creutzberg EC, Schols AM, etal. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006 Aug;100(8):1349e55.

Schols AM, Soeters PB, Dingemans AM, etal.Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993 May;147(5):1151e6.

Vestbo J, Prescott E, Almdal T,etal. Body mass, fat-freebody mass, and prognosis in patients with chronicobstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study.Am J Respir Crit Care Med 2006; 173: 79–83.

Bestall JC, Paul EA, Garrod R, etal. Usefulness of the Medical Research Council(MRC) dyspnoea scale as a measure of disability in patientswith chronic obstructive pulmonary disease. Thorax1999;54:581–6.

Pauwels RA, Buist AS, Calverley PM, etal. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256–76.

Standardization of Spirometry, 1994 Update. American Thoracic Society.Am J Respir Crit Care Med1995, 152(3):1107-1136.

Bioelectrical impedance analysis in body composition measurement:

National Institutes of Health Technology Assessment Conference Statement.

Am J Clin Nutr 1996;64(suppl):524S–32S

WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet363: 157–163.

Fess EE. Grip Strength, 2nd edition. Chicago: American Society of Hand Therapists, 1992.

Barreiro E, Ferrer D, Sanchez F,etal. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol 111: 808–817, 2011.

Eleni Ischaki, Georgios Papatheodorou, Eleni Gaki,

etal. Body Mass and Fat-Free Mass Indice in COPD. 2007;132:164–169

Roxana G Galesanu MD, Sarah Bernard, Karine Marquis, etal. Obesity and chronic obstructive pulmonary disease:Is fatter really better?. Can Respir 2014;21(5):297-301.

Vermeeren MA, Creutzberg EC, Schols AM,etal. Prevalence of nutritional depletion in a large out-patient population ofpatients with COPD. Respir Med 2006;100(8):1349e55.

Tewe L. Verhage , Yvonne Heijdra, Johan Molema, etal . Associations of muscle depletion with health status. Another gender difference

in COPD?. Clinical Nutrition 2011;30: 332-338.

Hyeon-Kyoung Koo, Joo-Hyun Park, Hye Kyeong Park, etal. Conflicting Role of Sarcopenia and Obesity in Male Patients with Chronic Obstructive Pulmonary Disease:

Korean National Health and Nutrition Examination Survey. PLOS ONE 2012;9(10): ):e110448.

Refbacks

  • There are currently no refbacks.